1. [Synthesis of cell penetrating peptide decorated magnetic nanoparticles loading cisplatin for nasopharyngeal cancer therapy].
- Author
-
Quan LM, Zhong Y, and Weng HH
- Subjects
- Cell Line, Tumor, Cell-Penetrating Peptides, Humans, Nanoparticles, Peptide Fragments, Polyethylene Glycols, Spectroscopy, Fourier Transform Infrared, tat Gene Products, Human Immunodeficiency Virus, Antineoplastic Agents administration & dosage, Cisplatin administration & dosage, Drug Delivery Systems, Magnetite Nanoparticles, Nasopharyngeal Neoplasms drug therapy
- Abstract
Objective: To synthesize cisplatin loaded and cell penetrating peptide TAT decorated magnetic nanoparticles and to observe the inhibiting effect in vitro on nasopharyngeal cancer therapy. Method: The aldehyde sodium alginate coated magnetic nanoparticles (ASA-MNPs) was prepared as the drug delivery system, which was covalently attached by PEGylation TAT (TAT-ASA-MNPs) via condensation of aldehyde with amino group and then coordinated with cisplatin (TAT-ASA-MNPs@CDDP). The complex was characterized by H-NMR and FT-IR. The cell penetrating ability and biocompatibility were observed by means of fluorescent tags. The inhibited effect on nasopharyngeal cancer CNE-2 cells was measured by cellular toxicity research and flow cytometry. Result: The H NMR and FT-IR of TAT-ASA-MNPs exhibited the characteristic peaks of TAT, PEG as well as ASA. The dynamic light scattering showed the hydrodynamic diameter of the complex was(145.9±1.5)nm. Zeta potential was(-21.66±1.24)mV and the drug loading rate was(25.03±3.05)%. Fluorescent labeling assay revealed that FITC marked TATASAMNPs was quickly taken up by CNE-2 cells. Cytotoxicity experiment on 293T cells displayed high survival rate (>70%) after cultured for 72h. Negative hemagglutination reflected decent biocompatibility. In vitro cytotoxicity test and cell apoptosis assay exhibited obvious inhibition on CNE-2 cell with TATASAMNPs@CDDP at low concentration of cisplatin compared to ASA-MNPs@CDDP ( P <0.05). Conclusion: TAT-ASA-MNPs showed decent biocompatibility while distinctly inhibit CNE-2 cells in vitro study., Competing Interests: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose., (Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.)
- Published
- 2018
- Full Text
- View/download PDF